Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print September 13, 2007, doi:10.1212/01.wnl.0000275524.15125.f4)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000275524.15125.f4v1
69/18/1745    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winkler, S.
Right arrow Articles by Klein, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winkler, S.
Right arrow Articles by Klein, C.
Received February 15, 2007
Accepted May 21, 2007

{alpha}-Synuclein and Parkinson disease susceptibility

S. Winkler BS, J. Hagenah MD, S. Lincoln BS, M. Heckman MS, K. Haugarvoll MD, K. Lohmann-Hedrich PhD, V. Kostic MD, M. Farrer PhD, and C. Klein MD*

From the Departments of Neurology (S.W., J.H., K.L.-H., C.K.) and Human Genetics (S.W., K.L.-H., C.K.), University of Lübeck, Lübeck, Germany; Department of Neuroscience, Mayo Clinic, Jacksonville, FL (S.L., M.H., K.H., M.F.); and Department of Neurology, University of Belgrade, Belgrade, Serbia and Montenegro (V.K.).


* To whom correspondence should be addressed. E-mail: christine.klein{at}neuro.uni-luebeck.de.

ABSTRACT

Background: Mutations in the {alpha}-synuclein (SNCA) gene have been shown to be responsible for a rare familial form of Parkinson disease (PD). Furthermore, polymorphic variants in multiple regions of the gene have been associated with susceptibility to idiopathic PD in different populations.

Objective: To evaluate and to confirm the role of SNCA variants in PD pathogenesis.

Methods: We included 667 subjects (397 cases with idiopathic PD and 270 healthy, ethnically matched controls) of Northern Central and Southeastern European origin. We analyzed genotypes at 14 markers spanning the SNCA locus and its major haplotype blocks and conducted a haplotype analysis for four promoter markers including the microsatellite marker Rep1.

Results: The three single nucleotide polymorphisms (SNPs) of the promoter region (rs2583988, rs2619364, rs2619363) and a SNP in the 3'UTR (rs356165) of the SNCA gene showed the greatest evidence for an association with PD (p ≤ 0.003), with significant pairwise values for linkage disequilibrium (D'≥ 0.74, r 2 ≥ 0.29). The promoter haplotype "261-T-G-T" (Rep1-rs2583988-rs2619364-rs2619363) was associated with disease (p = 0.032). The most significant association with PD was generated by excluding Rep1 (p = 0.008). This association remained significant when analyzing the Serbian patients separately and was of borderline significance for the German patients.

Conclusions: Our findings confirm that genetic variability within the SNCA locus is associated with susceptibility to idiopathic Parkinson disease (PD). We found evidence for disease association with single nucleotide polymorphisms at both the 5'and the 3'end of the gene with pairwise linkage disequilibrium between them. The association was independent of the Rep1 status, and one major SNCA promoter haplotype class seems to be associated with PD susceptibility.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
K. D. Cronin, D. Ge, P. Manninger, C. Linnertz, A. Rossoshek, B. M. Orrison, D. J. Bernard, O. M.A. El-Agnaf, M. G. Schlossmacher, R. L. Nussbaum, et al.
Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human {alpha}-synuclein in transgenic mouse brain
Hum. Mol. Genet., September 1, 2009; 18(17): 3274 - 3285.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Marek and D. Jennings
Can we image premotor Parkinson disease?
Neurology, February 17, 2009; 72(7_Supplement_2): S21 - S26.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. J. Farrer
Lrrk2 in the limelight!
Neurology, October 30, 2007; 69(18): 1732 - 1733.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.